-
1.发明公开
公开(公告)号：EP2323680A4
公开(公告)日：2013-05-01
申请号：EP09800676
申请日：2009-07-23
申请人： VIRAL GENETICS INC , UNIV COLORADO
CPC分类号： A61K35/26 , A61K38/08 , A61K38/10 , C07K14/47 , G01N33/56988 , G01N2333/5759
摘要： The present invention describes compositions of thymus derived peptides and uses therefore in diagnostic methods and for the treatment of diseases associated with reduced T helper cell counts, diseases such as infection, e.g., HIV infection and other viral infections, parasitic, and bacterial infection, AIDS, ARC, multiple sclerosis, chronic fatigue syndrome, rheumatoid arthritis, Alzheimer's disease, asthma, allergy, dermatitis, type 1 diabetes mellitus, colitis, inflammatory bowel disease/irritable bowel syndrome, Crohn's disease, Psoriasis, Chronic obstructive pulmonary disease, Systemic lupus erythematosus, transplant rejection and cancer.
-
公开(公告)号：EP2323679A4
公开(公告)日：2012-08-22
申请号：EP09800699
申请日：2009-07-23
申请人： UNIV COLORADO , VIRAL GENETICS INC
CPC分类号： A61K45/06 , A61K38/08 , A61K2300/00
摘要： The invention relates to methods for modulating the immune function through targeting of CLIP molecules. The result is wide range of new therapeutic regimens for treating, inhibiting the development of, or otherwise dealing with, a multitude of illnesses and conditions, including autoimmune disease, allergic disease transplant and cell graft rejection, cancer, bacterial infection, HIV infection, and AIDS.
-
3.发明公开Clip inhibitors and methods of modulating immune function 审中-公开夹子 - 血液和Verfahren zur Modulation der Immunfunktion
公开(公告)号：EP2633864A1
公开(公告)日：2013-09-04
申请号：EP13155864.5
申请日：2009-07-23
CPC分类号： A61K45/06 , A61K38/08 , Y02A50/401 , Y02A50/409 , Y02A50/411 , Y02A50/465 , Y02A50/471 , Y02A50/475 , Y02A50/57 , A61K2300/00
摘要： The invention relates to methods for modulating the immune function through targeting of CLIP molecules. The result is wide range of new therapeutic regimens for treating, inhibiting the development of, or otherwise dealing with, a multitude of illnesses and conditions, including autoimmune disease, allergic disease transplant and cell graft rejection, cancer, bacterial infection, HIV infection, and AIDS.
摘要翻译： 本发明涉及通过靶向CLIP分子调节免疫功能的方法。 其结果是广泛的新的治疗方案，用于治疗，抑制多种疾病和病症的发展或以其他方式处理，包括自身免疫疾病，过敏性疾病移植和细胞移植排斥，癌症，细菌感染，HIV感染和 艾滋病。
-
公开(公告)号：EP2089420A4
公开(公告)日：2011-04-27
申请号：EP07867230
申请日：2007-10-15
申请人： VIRAL GENETICS INC
发明人： AGADJANYAN MICHAEL , KELEDJIAN HAIG
CPC分类号： A61K38/57 , A61K2300/00
摘要： The present invention describes a composition comprised on cystatin A and at least one histone used in diagnostic tools and for the treatment of diseases associated with reduced T helper cell counts such as HIV-1 infection, AIDS, ARC, multiple sclerosis, chronic fatigue syndrome, heumatoid arthritis, Alzheimer's disease, dermatitis, type 1 diabetes mellitus, colitis, inflammatory bowel disease / irritable bowel syndrome, Crohn's disease, Psoriasis, Chronic obstructive pulmonary disease, System lupus erythematosus, transplant rejection and cancer.
-
5.发明公开
公开(公告)号：EP2089420A2
公开(公告)日：2009-08-19
申请号：EP07867230.0
申请日：2007-10-15
申请人： Viral Genetics, Inc.
CPC分类号： A61K38/57 , Y02A50/471 , A61K2300/00
摘要： The present invention describes a composition comprised on cystatin A and at least one histone used in diagnostic tools and for the treatment of diseases associated with reduced T helper cell counts such as HIV-1 infection, AIDS, ARC, multiple sclerosis, chronic fatigue syndrome, heumatoid arthritis, Alzheimer's disease, dermatitis, type 1 diabetes mellitus, colitis, inflammatory bowel disease / irritable bowel syndrome, Crohn's disease, Psoriasis, Chronic obstructive pulmonary disease, System lupus erythematosus, transplant rejection and cancer.
-
6.发明公开
公开(公告)号：EP2323680A2
公开(公告)日：2011-05-25
申请号：EP09800676.0
申请日：2009-07-23
CPC分类号： A61K35/26 , A61K38/08 , A61K38/10 , C07K14/47 , G01N33/56988 , G01N2333/5759 , Y02A50/401 , Y02A50/57
摘要： The present invention describes compositions of thymus derived peptides and uses therefore in diagnostic methods and for the treatment of diseases associated with reduced T helper cell counts, diseases such as infection, e.g., HIV infection and other viral infections, parasitic, and bacterial infection, AIDS, ARC, multiple sclerosis, chronic fatigue syndrome, rheumatoid arthritis, Alzheimer's disease, asthma, allergy, dermatitis, type 1 diabetes mellitus, colitis, inflammatory bowel disease/irritable bowel syndrome, Crohn's disease, Psoriasis, Chronic obstructive pulmonary disease, Systemic lupus erythematosus, transplant rejection and cancer.
-
公开(公告)号：EP2323679A2
公开(公告)日：2011-05-25
申请号：EP09800699.2
申请日：2009-07-23
CPC分类号： A61K45/06 , A61K38/08 , Y02A50/401 , Y02A50/409 , Y02A50/411 , Y02A50/465 , Y02A50/471 , Y02A50/475 , Y02A50/57 , A61K2300/00
摘要： The invention relates to methods for modulating the immune function through targeting of CLIP molecules. The result is wide range of new therapeutic regimens for treating, inhibiting the development of, or otherwise dealing with, a multitude of illnesses and conditions, including autoimmune disease, allergic disease transplant and cell graft rejection, cancer, bacterial infection, HIV infection, and AIDS.
-
-
-
-
-
-
搜索结果
7 条记录 (耗时 0.02 秒)
